For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Coronary artery disease is a very common type of heart disease. It occurs when the arteries that supply blood to the heart muscle harden and become narrow owing to the buildup of cholesterol and other materials on their inner walls. This results in insufficient blood and oxygen flow through the arteries to the heart muscle, hampering its normal functioning. This can lead to chest pain and heart attack. The major reason behind a heart attack is the sudden discontinuation of blood supply to the heart, which permanently damages the organ. Coronary artery diseases also weaken the heart muscle and contribute to heart failure and arrhythmias.
Scope of the Report:
This report focuses on the Drug-Eluting Balloons in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Increasing aging population, rising obesity, and increasing prevalence of coronary artery diseases are key drivers for the global drug-eluting balloons market. Also, advanced applications of drug-eluting balloons and increased government support in the form of funding and research has fueled the growth of this market.
The worldwide market for Drug-Eluting Balloons is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Market Segment by Regions, regional analysis covers
-North America (United States, Canada and Mexico)
-Europe (Germany, France, UK, Russia and Italy)
-Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
-South America (Brazil, Argentina, Colombia etc.)
-Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
-Below Knee Lesions
Market Segment by Applications, can be divided into
-Ambulatory Surgical Centers
There are 15 Chapters to deeply display the global Drug-Eluting Balloons market.
Chapter 1, to describe Drug-Eluting Balloons Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Drug-Eluting Balloons, with sales, revenue, and price of Drug-Eluting Balloons, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Drug-Eluting Balloons, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Drug-Eluting Balloons market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Drug-Eluting Balloons sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source